In addition to representatives of some of the leading manufacturers of insulins and glucose self-monitoring devices for diabetes, participants included experts from global health organisations, procurement agencies and government bodies.
The roundtable was held under the Chatham House Rule, in order to encourage a free and open exchange of ideas. It was moderated by the Access to Medicine Foundation's CEO, Jayasree K. Iyer, and was the latest event in the Foundation's Diabetes Care Programme.
Takeaways from the event
Points raised during the discussion, as well as examples of challenges and solutions, have been summarised in the meeting report under the following five headers:
Engage and involve people living with diabetes;
Develop business models and products specifically for LMICs;
Increase the involvement of and partnership with device manufacturers;
Shape a collaborative supply chain to the last mile;
Scale up healthcare capacity locally to support Universal Healthcare (UHC).
These five points each highlight some of the practical steps that companies can take to expand access to diabetes care in LMICs. Further details of the discussion are shared in the PDF of the meeting report.